Peripherally Administered Human Umbilical Cord Blood Cells Reduce Parenchymal and Vascularβ-Amyloid Deposits in Alzheimer Mice
- 1 June 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in Stem Cells and Development
- Vol. 17 (3), 423-440
- https://doi.org/10.1089/scd.2008.0018
Abstract
Modulation of immune/inflammatory responses by diverse strategies including amyloid-β (Aβ) immunization, nonsteroidal anti-inflammatory drugs, and manipulation of microglial activation states has been shown to reduce Alzheimer's disease (AD)-like pathology and cognitive deficits in AD transgenic mouse models. Human umbilical cord blood cells (HUCBCs) have unique immunomodulatory potential. We wished to test whether these cells might alter AD-like pathology after infusion into the PSAPP mouse model of AD. Here, we report a marked reduction in Aβ levels/β-amyloid plaques and associated astrocytosis following multiple low-dose infusions of HUCBCs. HUCBC infusions also reduced cerebral vascular Aβ deposits in the Tg2576 AD mouse model. Interestingly, these effects were associated with suppression of the CD40–CD40L interaction, as evidenced by decreased circulating and brain soluble CD40L (sCD40L), elevated systemic immunoglobulin M (IgM) levels, attenuated CD40L-induced inflammatory responses, and reduced surface expression of CD40 on microglia. Importantly, deficiency in CD40 abolishes the effect of HUCBCs on elevated plasma Aβ levels. Moreover, microglia isolated from HUCBC-infused PSAPP mice demonstrated increased phagocytosis of Aβ. Furthermore, sera from HUCBC-infused PSAPP mice significantly increased microglial phagocytosis of the Aβ1-42 peptide while inhibiting interferon-γ-induced microglial CD40 expression. Increased microglial phagocytic activity in this scenario was inhibited by addition of recombinant CD40L protein. These data suggest that HUCBC infusion mitigates AD-like pathology by disrupting CD40L activity.Keywords
This publication has 85 references indexed in Scilit:
- Transcutaneous β-amyloid immunization reduces cerebral β-amyloid deposits without T cell infiltration and microhemorrhageProceedings of the National Academy of Sciences of the United States of America, 2007
- Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer DiseaseJournal of Neuroscience, 2006
- CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid β‐peptideEuropean Journal of Immunology, 2005
- Brain Insulin Impairs Amyloid-β(1-40) Clearance from the BrainJournal of Neuroscience, 2004
- Neuroinflammatory perspectives on the two faces of Alzheimer?s diseaseJournal of Neural Transmission, 2004
- Alzheimer disease and cerebrovascular pathology: an updateJournal of Neural Transmission, 2002
- The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formationNeurobiology of Aging, 2001
- On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE)Journal of Neural Transmission, 2001
- Structural and Functional Disruption of Vascular Smooth Muscle Cells in a Transgenic Mouse Model of Amyloid AngiopathyThe American Journal of Pathology, 2001
- CD45 Inhibits CD40L-induced Microglial Activation via Negative Regulation of the Src/p44/42 MAPK PathwayPublished by Elsevier BV ,2000